Androski Lindsay (CIK 1936604) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-02). Recent activity: Buy ABUS (28,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-02 | Arbutus Biopharma Corp (ABUS) | President and CEO | Buy | 28,000 | $0 |
Source: SEC Form 4 filings · as of 2026-02-02